Amphix Bio, a pre-clinical stage company developing a new therapeutic modality for regenerative medicine, received an Orphan ...

Shardul Nautiyal, Mumbai Wednesday, July 16, 2025, 08:00 Hrs [IST] ...

LogiCare3PL, a division of BioCare, Inc., is pleased to announce a strategic partnership with ChiRhoClin, Inc., a leader in pancreatic and gastrointestinal diagnostics. Effective July 14, 2025, ...

LogiCare3PL, a division of BioCare Inc., has partnered with ChiRhoClin Inc., a leader in pancreatic and gastrointestinal ...

The antibody anselamimab, which AstraZeneca picked up in its 2021 purchase of Caelum Biosciences, failed to improve survival and reduce hospitalizations, but the company sees promise in data from an ...

As lawmakers weigh potential cuts to scientific research funding, the outlook for developing cancer cures faces growing ...

WHERE IS DEA'S DEPUTY THOMAS PREVOZNIK HIDING?Bright Green Corp: The DEA-Enabled Stock Market Swindle Files For Bankruptcy."Terrance Cole, the nominee for DEA Administrator, must confront this DEA rot ...

David Mulligan, PhD, previews the FDA's ODAC meeting discussing the application of belantamab mafodotin-based combinations for the treatment of multiple myeloma.

Neurofibromatosis Type 2 Market Insight, Epidemiology and Market Forecast - 2034The Neurofibromatosis Type 2 treatment market is experiencin ...

Drugmaker Swedish Orphan Biovitrum AB’s Chief Executive Officer Guido Oelkers said he doesn’t think tariff threats on the ...

Detailed price information for Oncolytics Biotech Inc (ONCY-Q) from The Globe and Mail including charting and trades.

VYKAT XR launch generates $32M, addressing unmet Prader-Willi needs. Soleno (SLNO) stock fairly valued; potential buyout ...